Bessemer Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137M Sell
285,431
-31,609
-10% -$16.2M 0.22% 115
2025
Q4
$178M Sell
317,040
-24,877
-7% -$14.1M 0.27% 93
2025
Q3
$176M Sell
341,917
-165,755
-33% -$72.4M 0.27% 93
2025
Q2
$159M Sell
507,672
-74,597
-13% -$22.4M 0.26% 101
2025
Q1
$177M Buy
582,269
+6,225
+1% +$2.09M 0.32% 77
2024
Q4
$191M Buy
576,044
+75,275
+15% +$25.5M 0.31% 77
2024
Q3
$167M Buy
500,769
+16,279
+3% +$6.18M 0.28% 101
2024
Q2
$200M Buy
484,490
+89,656
+23% +$35.5M 0.35% 71
2024
Q1
$160M Buy
394,834
+6,137
+2% +$2.16M 0.29% 101
2023
Q4
$119M Buy
388,697
+106,907
+38% +$28.9M 0.23% 118
2023
Q3
$68.2M Buy
281,790
+281,756
+828,694% +$72.1M 0.15% 165
2023
Q2
$8K Buy
34
+21
+162% +$4.36K ﹤0.01% 1700
2023
Q1
$2K Sell
13
-16
-55% -$3.31K ﹤0.01% 1816
2022
Q4
$6K Sell
29
-31
-52% -$6.19K ﹤0.01% 1528
2022
Q3
$10K Buy
60
+9
+18% +$1.44K ﹤0.01% 1553
2022
Q2
$8K Hold
51
﹤0.01% 1419
2022
Q1
$8K Hold
51
﹤0.01% 1431
2021
Q4
$11K Hold
51
﹤0.01% 1398
2021
Q3
$10K Buy
+51
New +$9.3K ﹤0.01% 1377
2020
Q3
Sell
-19,700
Closed -$1.83M 1538
2020
Q2
$1.83M Buy
19,700
+4,800
+32% +$408K 0.01% 510
2020
Q1
$1.09M Buy
+14,900
New +$1.29M ﹤0.01% 585
2019
Q4
Sell
-199
Closed -$17K 1718
2019
Q3
$17K Buy
+199
New +$15K ﹤0.01% 1423

Other funds holding MEDP

Bessemer Group's MEDP Position: Q1 2026 in Review

Bessemer Group reduced its Medpace (MEDP) stake by 10% in Q1 2026, selling an estimated $16.2M and leaving 285,431 shares worth $137M. The position accounts for 0.22% of the portfolio, ranked #115.

Bessemer Group first reported a position in MEDP in Q3 2019 and has held it in 22 quarters since. The position peaked at $200M in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Bessemer Group held 285,431 shares of Medpace worth $137M as of Q1 2026.
  • Bessemer Group sold 31,609 Medpace shares in Q1 2026, an estimated $16.2M.
  • Medpace made up 0.22% of Bessemer Group's portfolio in Q1 2026, its #115 holding.
  • Bessemer Group first reported a position in Medpace in Q3 2019 and has held it in 22 quarters since.
  • Bessemer Group's Medpace position peaked at $200M in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.